Drug Research - Latest News & Updates on Drug Research

Integrated Drug Development Consulting for Pharmaceuticals

Yuvraj — Mon, 30 Mar 2026 11:41:34 +0000

Strategic oversight and regulatory navigation in the pharmaceutical industry rely on an integrated approach to drug development consulting, ensuring that global clinical pipelines reach the market efficiently.

The post Integrated Drug Development Consulting for Pharmaceuticals first appeared on World Pharma Today.

Inside Cryopreservation: Key Steps and Scientific Insights

Yuvraj — Wed, 25 Mar 2026 12:10:54 +0000

It may sound like science fiction to the layperson, but cryopreservation is here, and it’s bridging the gap between what’s medically possible today and the potential of future technologies. This technology sits at the intersection of biotechnology, medicine and long-term patient care. Cryonics extends the principles of stasis maintenance to the human body, focusing on […]

The post Inside Cryopreservation: Key Steps and Scientific Insights first appeared on World Pharma Today.

ICON Advarra Partnership Builds Research-Ready Trial Model

Yuvraj — Wed, 25 Mar 2026 07:51:15 +0000

ICON, a world-leading clinical research organisation, has formalised a definitive partnership agreement with Advarra to introduce a new research-ready trial model designed to reshape how clinical trials are conducted. The collaboration brings together ICON’s global clinical trial solutions with Advarra’s established suite of site technologies, aiming to create a more connected and efficient operating framework […]

The post ICON Advarra Partnership Builds Research-Ready Trial Model first appeared on World Pharma Today.

Novartis China Investment Expands R&D and Manufacturing

Yuvraj — Tue, 24 Mar 2026 13:38:24 +0000

Novartis is stepping up its presence in China with a fresh wave of capital deployment, underscoring the country’s growing role in global pharmaceutical strategy. The company confirmed a Novartis China investment exceeding 3.3 billion Chinese yuan (roughly $480 million), aimed at expanding manufacturing capabilities in Beijing while advancing research operations in Shanghai. The announcement was […]

The post Novartis China Investment Expands R&D and Manufacturing first appeared on World Pharma Today.

Egypt-Takeda Pharmaceutical Cooperation Boosts R&D Push

Yuvraj — Thu, 19 Mar 2026 09:19:16 +0000

Egypt is stepping up its push to reinforce its pharmaceutical research landscape by deepening pharmaceutical cooperation with Takeda Pharmaceutical Company, aligning with a wider national agenda to strengthen healthcare capabilities and drug development infrastructure. In this context, the Egyptian Drug Authority (EDA) convened high-level discussions with a senior Takeda delegation to explore ways to expand […]

The post Egypt-Takeda Pharmaceutical Cooperation Boosts R&D Push first appeared on World Pharma Today.

Online Medicine in India Where Ganaton Total Fits in Modern Digestive Care

Yuvraj — Wed, 18 Mar 2026 08:35:24 +0000

The demand for online medicine delivery in India has grown rapidly as patients seek convenience without compromising on authenticity. With chronic digestive disorders on the rise, many physicians prescribe combination therapies such as Ganaton Total to manage complex gastrointestinal symptoms. Trusted digital pharmacies like PlatinumRx are helping bridge the gap between prescription access and safe […]

The post Online Medicine in India Where Ganaton Total Fits in Modern Digestive Care first appeared on World Pharma Today.

Roche AI Factory Expansion to Boost Pharma R&D Capacity

Yuvraj — Wed, 18 Mar 2026 08:10:47 +0000

Swiss drugmaker Roche has expanded its artificial intelligence infrastructure by deploying more than 2,100 NVIDIA chips, strengthening its computational capabilities to accelerate drug and diagnostics development. The move, centred on a large-scale Roche AI factory, reflects the company’s ongoing investment in advanced computing to streamline research and development processes across its global operations. The expansion […]

The post Roche AI Factory Expansion to Boost Pharma R&D Capacity first appeared on World Pharma Today.

Enhertu Priority Review in HER2-Positive Early Breast Cancer

Yuvraj — Wed, 11 Mar 2026 08:14:38 +0000

The supplemental Biologics License Application – sBLA for Enhertu – trastuzumab deruxtecan by AstraZeneca and Daiichi Sankyo has been accepted as well as granted Priority Review in the U.S. when it comes to the treatment of adult patients with HER2‑positive early breast cancer who happen to have residual invasive disease after neoadjuvant HER2‑targeted therapy. Enhertu […]

The post Enhertu Priority Review in HER2-Positive Early Breast Cancer first appeared on World Pharma Today.

Lilly Launches New AI Supercomputer for Drug Development

Yuvraj — Mon, 02 Mar 2026 13:45:04 +0000

Eli Lilly has launched what it describes as the most powerful AI factory wholly owned and operated by a pharmaceutical company, marking a significant expansion of advanced computing infrastructure in life sciences. The system, named LillyPod, was inaugurated in Indianapolis and is built as the world’s first NVIDIA DGX SuperPOD with DGX B300 systems, powered […]

The post Lilly Launches New AI Supercomputer for Drug Development first appeared on World Pharma Today.

Contamination Control with Toxicological Reference Data

Yuvraj — Mon, 23 Feb 2026 07:59:32 +0000

Centralizing expert-verified toxicological datasets is now a critical requirement for modern pharmaceutical facilities operating under stringent global regulations. By transitioning from generic cleaning limits to precise Health-Based Exposure Limits derived from high-quality platforms, manufacturers ensure that cleaning validation protocols are scientifically sound and audit-ready. This approach integrates rigorous toxicological risk assessment into the broader contamination control strategy, safeguarding patient health while optimizing multi-product manufacturing efficiency and regulatory compliance.

The post Contamination Control with Toxicological Reference Data first appeared on World Pharma Today.